MDT logo
MDT@NYSE
Medtronic Plc
$ 88.48+0.73 (+0.83%)
MDT 매수
시가장 시작 가격
—
저가오늘 최저가
—
52주 최고가최근 52주 최고가
—
고가오늘 최고가
—
52주 최저가최근 52주 최저가
—
시가총액기업 총가치
112.32B
오늘 거래량오늘 거래량
105.66M
평균 거래량평균 거래량
11.36M
주가수익비율 (P/E)주가수익비율
21.45

기업 정보

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

IPO 날짜
1973-05-02
본사
Galway, IE
CEO
Geoffrey Straub Martha
섹터
Healthcare
산업
Medical - Devices

재무제표

실적

관련 기업

688617.SS logo
688617.SSAPT Medical Inc.
242.85
AVR logo
AVRAnteris Technologies Global Corp.
6.77
BSX logo
BSXBoston Scientific Corporation
42.73
EW logo
EWEdwards Lifesciences Corporation
85.21

거래의 미래를 열다

AI 기반 인사이트로 더 스마트하고 자신감 있는 거래를 위한 글로벌 시장에 대한 원활한 액세스.

디바이스 목업